Vets First Choice
$223 Million - Private PlacementExclusive Financial Advisor
Regulus Therapeutics Inc.
$46 Million - Follow-OnSole Bookrunner
CymaBay Therapeutics, Inc.
$97 Million - Follow-OnJoint Bookrunner
ALGN / Bullish MEDACorp Call For ALGN; Teen May Be Nearing An Inflection
VRTX / Plenty of Promising Signs in Mgmnt Meeting – Is VX-445 the Best?
Medical Devices-Cardiology / TAVR Survey: Suggests Mid-High Single Digit 1Q17 Market Growth, Ahead of Street